a r t i c l e s miRNAs are a class of about 1,000 noncoding RNAs that in mammals regulate about half of the protein-encoding genes by enhancing their degradation or preventing their translation 1,2 . After transcription, the long primary miRNA (pri-miRNA) transcripts are processed to 60-to 80-nt precursor miRNAs (pre-miRNAs) and are subsequently cleaved to mature ~22-nt-long duplex RNAs 3,4 . With a few exceptions 5,6 , the pre-miRNAs have been considered to be mere intermediates of the miRNA biogenesis pathway rather than gene regulators by themselves.
a r t i c l e s with a 902-bp region (out of 1,360 nt) of the 3′ UTR of wild-type E2f6. Overexpression of sh-151-5p resulted in a robust repression (~80%) relative to a scrambled control (sh-scr) ( Fig. 1c) . Correction of the one seed-region mismatch present in the E2f6 3′ UTR to mimic the perfectly base-paired human E2F6-miR-151-5p pair (per 5p) had no further effect on the repression of E2f6 by miR-151-5p, thus indicating that the sequence difference between the human and mouse E2f6-miR-151-5p pair has no functional consequence. In contrast, placement of four mutations in the E2f6 seed region (mut 5p) reduced the repression from 80% to 25% (Fig. 1c) . Western blot analysis after cotransfection with an E2f6 expression plasmid, containing its entire coding sequence and 3′ UTR, along with sh-151-5p showed that intact E2f6 protein production was substantially inhibited (Fig. 1d) , corroborating the results from the reporter assays. Likewise, overexpression of miR-151-5p caused a dramatic reduction in endogenous E2f6 mRNA levels as shown by quantitative PCR (qPCR) (Fig. 1e) . Furthermore, a miR-151-5p inhibitor specifically blocked the ability of endogenous miR-151-5p to downregulate expression of the E2f6 3′-UTR reporter in a dose-dependent manner (Fig. 1f) . All of these experiments indicate that miR-151-5p is able to target the E2f6 3′ UTR.
We used two lines of evidence to establish that miR-151-5punlike most mammalian miRNAs, which mediate gene knockdown by noncleavage repression processes-suppressed mouse E2f6 expression by the more robust Ago2-mediated cleavage mechanism. First, in Ago2-null (Ago2 −/− ) MEFs incapable of cleavage-mediated miRNA knockdown 33 , we observed only ~25% repression ( Fig. 1g ) by reporter assay. Moreover, we could rescue the robust miR-151mediated repression of E2f6 when wild-type but not catalytically inactive Ago2 (D597A mutation in the PIWI domain) 33 or cleavageincompetent Ago1 was added back to the Ago2 −/− cells 34 (Fig. 1g) . Second, we detected an E2f6 cleavage product in mouse lung tissue by using a modified 5′ rapid amplification of cDNA ends (5′ RACE) assay. Sequencing of the 5′-RACE clones confirmed the expected position of the 5′ end of the E2f6 cleavage product (8 of 11 clones from the amplicon with the expected size), which mapped to the tenth nucleotide that pairs with miR-151-5p ( Fig. 1h) . To confirm that the cleavage product of E2f6 was due to miR-151-5p, we cotransfected MEF cells with a scrambled control (sh-scr) or sh-151-5p along with an E2f6-overexpression plasmid. We detected an E2f6 cleavage product of expected size only in the presence of coexpressed miR-151-5p ( Fig. 1h) . We did not detect cleavage product when sh-151-3p overexpressing the miR-151 passenger strand (3p) was coexpressed with E2f6 or when sh-151-5p was coexpressed with ARHGDIA ( Fig. 1h) , an established miR-151-5p target that lacks extensive complementarity with miR-151-5p 35 . Together, these results demonstrate that miR-151-5p-mediated cleavage of E2f6 mRNA is one of the rare instances in mammals in which a gene is targeted for cleavage by an miRNA, moreover in the absence of a complete seed match. During our studies, we noted that in humans, a putative binding site for the mature miR-151-3p arm with a miRNA-like seed region was only 9 nt away from the site where the mature miR-151-5p is expected to bind ( Fig. 2a) . In mice, a less canonical central basepairing seed-region match, but one still known to induce noncleavage repression 30 , was present ( Fig. 2a) . Interestingly, we found by reporter assay that the central 3p seed site conferred ~40% repression of E2f6 expression when we overexpressed miR-151-3p in MEF cells ( Fig. 2b and Supplementary Fig. 1a ). Point mutations of this center seed region (mut 3p) reduced the repression potential of the 3p site, whereas removal of the full 3p-binding site abolished the repression entirely ( Fig. 2b) . Increasing the complementarity of the seed region to include the more canonical 2-to 8-nt region of the mature miRNA (seed 3p) had no further effect on repression over the existing central seed match (Fig. 2b) . Absence of Ago2 did not change the miR-151-3p-mediated repression of E2f6 substantially, thus indicating a predominant non-cleavage-based mechanism (Fig. 2c) . This was also demonstrated by the 5′-RACE assay in which we failed to observe RNA fragments diagnostic of miR-151-3p-mediated cleavage of E2f6 (Fig. 1h) . Thus, miR-151-3p can repress E2f6 gene expression through the canonical miRNA repressive mechanism.
Precursor miR-151 antagonizes activity of mature miR-151
The homology of both the pre-miR-151 region and the E2f6 3′-UTR binding location is conserved specifically among placental mammals ( Supplementary Fig. 2a ). We questioned the biological importance served by having binding sites of miRNAs derived from both arms (5p and 3p) of the same pre-miRNA at adjacent positions within a 3′ UTR. Interestingly, in mice, these sites overlap with the most favorable binding location for the miR-151 precursor in the 3′ UTR of E2f6 (minimum free energy of -61.3 kcal/mol, calculated with RNAhybrid 36 ). Furthermore, thermodynamic considerations favor the binding of the miR-151 precursor to the E2f6 3′-UTR region (Fig. 3a) . Therefore, we pursued studies to determine whether pre-miR-151 can bind and compete with mature miR-151 for the overlapping sites within the E2f6 3′ UTR. Interestingly, pre-miR-151 is a substrate for RNA editing by ADAR1, whereby two A nucleosides are edited to inosine (I) 21 (Fig. 3b) .
These two I nucleosides result in an increase in the steady-state levels of pre-miR-151 (ref. 21) as well as an increase in pre-miR-151 affinity to the E2f6 3′ UTR (Supplementary Fig. 2b ).
To perform a competition assay between edited pre-miR-151 and mature miR-151 for the overlapping target, we first evaluated the effect of editing on precursor abundance and E2f6 expression in vivo. We used a Pol II-based pEZX construct that contains the endogenous miR-151 stem and loop sequences (pEZX-151) and a modified double-mutant version that incorporated two A-to-G point mutations (pEZX-DM) at the same positions where A-to-I editing occurs in vivo 21, 22 . Unlike the Pol III-based shRNA system, the system with Pol II-based constructs pEZX-151 and pEZX-DM generated pre-miR-151 (~56 nt) ( Fig. 3c) along with a higher-molecular-weight pri-miR-151 or intermediate of the miR-151 biogenesis pathway ( Supplementary Fig. 2c ). pEZX-151 processed more efficiently to mature miR-151-5p and miR-151-3p, as compared to pEZX-DM ( Fig. 3c ). Reporter assays in MEF cells showed that expression from the pEZX-151 construct that resulted in pre-miR-151 accumulation had less E2f6 3′ UTR-suppressive activity (~40%) ( Fig. 3d ) than that of the sh-151-5p (~80%) construct ( Fig. 3d) . Moreover, expression from pEZX-DM that had a higher precursor-to-mature miR-151 ratio resulted in a drastically reduced repressive activity on the E2f6 3′-UTR levels (~10%). This suggested that increasing the precursor-to-mature miR-151 ratio impeded the repression ability of miR-151 on E2f6, thereby supporting the possibility of a scenario in which pre-miR-151 binding to the E2f6 3′ UTR was able to mask the MRE from the mature miR-151-5p. However, the differences in E2f6 3′-UTR regulation could be explained in part by different levels of the mature miR-151-5p produced by the different constructs ( Fig. 3c) . This was especially the case when we compared the Pol II-based constructs (pEZX-151 and pEZX-DM) and the Pol III-based construct (sh-151-5p) because the latter produced more mature miR151-5p molecules. To rule out this possibility and to further investigate whether there was a competition between the precursor and mature miR-151-5p for their overlapping MRE sites, we modified the reporter containing E2f6 3′-UTR sequence in two ways. We removed the 3p-binding site in the E2f6 3′-UTR reporter construct (3p del) so that no thermodynamic advantage was provided to the precursor relative to mature 5p for binding to the target (Fig. 3e) . Moreover, we swapped the positions of the 3pand 5p-binding sites in the reporter construct (3p-5p swap) to reduce sh-scr npg a r t i c l e s the potential of the precursor to bind linearly across the E2f6 3′ UTR ( Fig. 3e) . Indeed, in vitro gel shift assays showed that the pre-miR-151 bound to the putative 3′-UTR region of E2f6 in a dosedependent manner ( Fig. 3f) , but there was no stable interaction between the precursor and the 3p-5p-swap or the 3p-del target constructs ( Fig. 3f) . Upon modifying the target (3p-5p swap or 3p del), we did not observe (by dual-luciferase assays) any major changes in the degree of E2f6 repression by the mature miR-151 forms (5p and 3p) ( Supplementary Fig. 2d ) with the exception of the 3p del, for which, as expected, there was no change in 3p-mediated E2f6 gene repression (also in Fig. 2b ). However, when pre-miR-151 was present but unable to bind to the modified target sites as in the Pol II-based pEZX system, miR-151 overexpression resulted in substantially more repression of E2f6 in both the target-site modifications (3p-5p swap and 3p del), compared to the wild-type E2f6 3′ UTR ( Fig. 3g) . Importantly, when relatively more pre-miR-151 accumulated by pEZX-DM overexpression (comparison of pEZX-DM to pEZX-151; Fig. 3c ), E2f6 was repressed to a greater extent in the modified target sites (3p-5p swap and 3p del) compared to the wild-type E2f6 3′ UTR ( Fig. 3g) . A miR-151 dose-response study corroborated these findings ( Supplementary  Fig. 2e ). Addition of increasing amounts of sh-151-5p consistently increased luciferase repression. However, constructs with an active precursor (either the pEZX-151 or pEZX-DM construct) reached steady-state levels indicating buffering or competition of the precursor with the mature miRNA. (Supplementary Fig. 2e ). Adding a locked nucleic acid (LNA)-DNA mixmer blocker, to weaken the binding of the pre-miR-151 to the E2f6 3′-UTR region and in turn disrupt the competition between pre-miR-151 and mature miR-151-5p, enhanced the repression of E2f6 expression by the pEZX-151 and pEZX-DM ( Supplementary Fig. 2f ). These studies do not rule out the alternative explanation that the absence of the 3p target site either by its removal (Fig. 3g ) or its blockage ( Supplementary Fig. 2f ) enhanced the activity of the miR-151-5p-mediated E2f6 repression, owing to less steric hindrance. We therefore asked whether the presence of the miR-151-3p-binding site could interfere with E2f6 repression by miR-151-5p. We used reporter assays with the construct containing the E2f6 3′ UTR and provided an increasing ratio of sh-151-5p to sh-151-3p in comparison to the same increasing ratio of sh-151-5p to sh-scr. We observed a greater repression of E2f6 by miR-151-5p binding in the presence of miR-151-3p compared to miR-151-5p alone (Supplementary Fig. 3a ). Consistently with this finding, we observed greater sh-151-5p-directed repression in the E2f6 3′-UTR reporter Figure 3 Precursor miR-151 competes with the mature miR-151-5p for binding to the E2f6 3′ UTR. (a) Thermodynamics of pre-miR-151 binding to E2f6. MFE, minimum free energy change (∆G). MFEs of binding of pre-miRNA with the target, folding of pre-miRNA and folding of target are denoted by ∆G PT , ∆G P and ∆G T , respectively. (b) Schematic of the stem-loop structure of the pre-miR-151 with the 5p arm (blue), 3p arm (purple) and two As (green) substituted to Gs (orange). (c) Northern analysis of miR-151 processing from pre-miR-151-overexpression plasmid (pEZX-151) or the double-mutant form of pre-miR-151 (pEZX-DM). Let-7a serves as a loading control. (d) Dualluciferase reporter assay for the E2f6 3′ UTR in the presence of only the mature miR-151-5p (sh-151-5p) or both the pre-miR-151 and mature miR-151-5p (pEZX-151 and pEZX-DM). (e) Schematic of the binding site of pre-miR-151 in the E2f6 3′ UTR and its modifications (E2f6 3p del and E2f6 3p-5p swap). (f) In vitro gel shift assay with radiolabeled (denoted by an asterisk) synthetic (syn)-pre-miR-151(I) or a control pre-miR-122 and increasing molar concentrations of wild-type E2f6 3′ UTR (1, 10 and 100 nM) or its modified forms. (g) Dual-luciferase analysis for E2f6 3′ UTR (WT), 3p-del or 3p-5p-swap reporters with pEZX-151 or pEZX-DM. For reporter assays (d,g), results are normalized to a scrambled control (sh-scr). Error bars, s.e.m. (n = 9 data points from three independent experiments measured in triplicate). NS, not significant; *P = 0.05; **P = 0.01 by two-tailed Student's t test.
(h) In vitro gel shift assay of the E2f6 3′ UTR bound to miR-151-5p with increasing molar concentrations of a synthetic pre-miR-151 or a control pre-miR-122. Bands below the blue star and orange star represent radiolabeled pre-miR-151 and pre-miR-122, respectively. Asterisks denote radiolabeled oligonucleotides. a r t i c l e s construct compared to the 3p deletion construct that lacks the miR-151-3p-binding site ( Supplementary Fig. 3b ). Hence, these results are inconsistent with the idea that the miR-151-3p -binding site in the E2f6 3′ UTR is antagonistic or poses steric hindrance to binding of the RNA-induced silencing complex at the miR-151-5p-binding site.
The above biological repression studies supporting the idea that the miR-151 precursor is able to compete with the mature form and to impede repression by mature miR-151 was further supported by in vitro gel-shift competition assays ( Fig. 3h) . Increasing concentrations of a synthetic pre-miR-151(I) competed with the binding of miR-151-5p to the MRE of the E2f6 3′ UTR (Fig. 3h) . Furthermore, to validate the competition model inside cells, we carried out reporter assays in Dicer-knockout cells to look at the effect of mature miR-151-5p alone or with increasing dosage of pre-miR-151 on E2f6 expression. Cells lacking Dicer are unable to process precursor miRNA, and we confirmed this by northern blot analysis in Dicer-knockout cells (Supplementary Fig. 2g ). By increasing the dosage of the doublemutant form of pre-miR-151 (pEZX-DM), we found that the repression of E2f6 by a synthetic miR-151-5p duplex was partially rescued, as predicted by the competition model ( Supplementary Fig. 2h ).
Pri- or pre-miR-151 protects E2f6 transcripts in quiescent tissues
Competition between the precursor and mature forms of miR-151 requires the direct binding of the pre-miR-151 to the E2f6 3′ UTR. To confirm such an interaction, we pursued two different studies. We first performed a biochemical pulldown assay using a synthetic and A-to-I-substituted pre-miR-151 from HEK293 cells cotransfected with the synthetic edited pre-miR-151 and an E2f6 expression construct, and we found an enrichment of the E2f6 3′-UTR targets in the pulled-down fraction. This result established that the pre-miR-151 was able to bind to the E2f6 3′ UTR inside cells ( Supplementary  Fig. 4 ). The pulldown result was also consistent with our findings from the gel shift assay discussed above (Fig. 3f) .
Our second approach was to corroborate the binding of the pre-miR-151 to endogenous E2f6 mRNA in vivo in a primary mammalian tissue. To do this, we performed a modified version of the chromatin isolation by RNA purification (ChIRP) assay 37 (outlined in Fig. 4a) . Because pre-miR-151 accumulates in the mammalian brain 21 , we added biotinylated tiling oligonucleotides complementary to the 3′ UTR of E2f6, or lacZ mRNA (absent in vertebrates) as a control, to mouse brain homogenates. After streptavidin pulldown, we established that the E2f6 3′-UTR tiling oligonucleotide-based pulldown samples were highly enriched for the E2f6 3′-UTR RNA compared to the neuronal-expressed Ctdnep1 mRNA control (Fig. 4b) . We also observed a substantial fold enrichment of pre-miR-151 compared to a control pre-miRNA ( Fig. 4c) in the E2f6 pulled-down samples. This strongly suggested a bona fide in vivo interaction between the pre-miR-151 and E2f6. Interestingly, we did not observe any enrichment of mature miR-151-5p in the E2f6 pulled-down fraction (Fig. 4d) , a result consistent with the cleavagebased degradation of E2f6 by miR-151-5p. Moreover, these results are also in concordance with the competition model whereby the pre-miR-151 masks the binding site of mature miR-151-5p. 
npg a r t i c l e s
To begin to unravel the biological importance of this interaction and the resulting unique regulatory circuit, which controls expression of a gene important in induction of cell-cycle exit and terminal differentiation 38 , we surveyed primary mouse tissues for the expression of primary and mature miR-151 and E2f6. We found endogenous expression of E2f6 and pri-miR-151 to be the highest in nondividing tissues such as brain, heart and skeletal muscle (Fig. 4e,f) . However, the amount of mature miR-151-5p was either lower than or similar to that in other tissues, such as the lung, spleen and liver, a result indicative of regulated processing of miR-151 between different tissues (Fig. 4g) . Northern analysis of miR-151 processing (Fig. 4h ) across these tissues suggests regulated processing of miR-151 and is consistent with the qPCR data mentioned above. Thus the high amount of precursors in nondividing tissues may help protect the E2f6 3′ UTR from cleavage by mature miR-151-5p. To corroborate the correlation between the expression of E2f6 and pri-miR-151, we checked their expression profiles during skeletal-muscle differentiation in C2C12 myoblast cells. Expression of both pri-miR-151 and E2f6 increased with C2C12 differentiation in a temporal fashion, whereas levels of the mature form of miR-151-5p remained unchanged (Fig. 4i) . On the basis of our model, the high levels of E2f6 mRNA were consistent with the pri-or pre-miRNA inhibition of mature miR-151-5p binding.
Pri- or pre-miR-151-mediated gene regulation is target specific
Although our studies implicated an antagonistic interaction of pre-miR-151 and mature miR-151 for E2f6, we investigated whether miR-151 transcripts could have opposing effects on mRNAs that are bona fide targets of miR-151. RhoGDIA (ARHGDIA), a GDP-GTPexchange regulator of the Rho proteins that inhibits cell invasion and migration, is a direct target of miR-151-5p and exhibits an inverse and functional relationship with expression of miR-151-5p (but not 3p) in hepatocellular carcinoma 35 . Our predictive thermodynamics analysis with RNAhybrid 36 did not favor pre-miR-151 antagonizing miR-151-5p binding in the ARHGDIA mRNA (Fig. 5a) , and we confirmed this experimentally by using dual-luciferase assays. First, we observed no significant difference in the repression of ARHGDIA expression with overexpression of either mature miR-151 (from the Pol III system, sh-151-5p) or pre-miR-151 (from the Pol II system, pEZX-151) in the reporter assay (Fig. 5c) . Second, we constructed and tested target-site (ARHGDIA) deletion modifications similar to E2f6, in which the pre-miR-151 would have no thermodynamic advantage over miR-151-5p for binding to the target MRE (Fig. 5b) . If there were a competition between the pre-miR-151 and mature miR-151 for an overlapping binding site in the ARHGDIA 3′ UTR, we would observe a drop in luciferase activity upon overexpression of pre-miR-151 (pEZX-151) in the target site-deletion construct (ARHGDIA 3p del) compared to the wild-type construct (ARHGDIA). However, overexpression of pre-miR-151 (pEZX-151) resulted in similar levels of ARHGDIA repression in both the wild-type and ARHGDIA 3p-del target constructs (Fig. 5c) . Therefore, unlike in E2f6, pre-miR-151 did not have an antagonistic interaction with miR-151-5p to regulate ARHGDIA expression.
Predicted widespread gene regulation by pre-miRNAs
Because the ratio of precursor to mature forms varies for many miR-NAs during development and cancer globally, we next asked whether other miRNA precursors might have a direct regulatory role in targetgene expression similar to that of the pre-miR-151-E2f6 pair. To do so, we developed a bioinformatics pipeline in which we combined miRNA-target-site predictions along with RNA folding analyses (flowchart in Supplementary Fig. 5a ). Quite surprisingly, we found 138 miRNAs predicted to target 1,607 mRNAs common to both mice and humans, for which the pre-miRNAs would be predicted to compete with the corresponding mature miRNAs for the same targets ( Fig. 6a and Supplementary Table 1) .
A second example: the SNAI2 mRNA-miR-124 pair
To obtain functional support for an independent competitive pre-miRNA regulation of a miRNA target, we selected a miRNA-target pair with a high ∆∆G score: the miR-124-SNAI2 pair. This came from a subset of our predicted list of miRNAs and cognate targets, specifically from interactions that have been experimentally validated and curated in the miRTarBase database 39 (Supplementary Table 2) . SNAI2 is a transcription factor overexpressed in various cancers 40 . Examination of the thermodynamic parameters showed that binding of pre-miR-124 to the MRE of mature miR-124 (miR-124-3p) in SNAI2 3′ UTR is favorable ( Fig. 6b) . We realized that unlike the E2f6-miR-151 example, the SNAI2-miR-124 pair would result not in mRNA cleavage but rather in classical miRNA-mediated repression, thus making the relative changes in expression less dramatic. Nevertheless, to validate the predicted competition between miR-124 and pre-miR-124 to target the SNAI2 3′ UTR, we cotransfected a reporter construct containing the SNAI2 3′ UTR with either the mature form of miR-124 (from a Pol III construct, sh-124, Supplementary Fig. 1b) or the precursor form of miR-124 (from a Pol II construct, pEZX-124, Supplementary Fig. 1c) . As expected, the presence of pre-miR-124 and mature miR-124 (pEZX-124) resulted in lesser repression of the SNAI2 target than did mature miR-124 only (sh-124). This suggested that pre-miR-124 limited the accessibility of mature miR-124 to its MRE in the SNAI2 3′ UTR (Fig. 6c) . To validate the competition, we created reporter constructs similar to those generated for E2f6, with modifications in the target MRE that would not favor binding of precursor miRNA over the mature miRNA (Fig. 6c) . The first modification was the swapping of the miRNA-124 3p and 5p complementary sites in the SNAI2 3′ UTR (SNAI2-swap). A second modification was the addition of a random sequence in the SNAI2 3′ UTR to disrupt the 5p complementary site (SNAI2-ran). Overexpression of miR-124 and pre-miR-124 from pEZX-124 resulted in greater repression in both the reporter constructs containing target modifications (SNAI2-swap and SNAI2-ran) compared to the unmodified SNAI2 3′ UTR-containing reporter construct, SNAI2 (Fig. 6c) . However, mature miR-124 (sh-124) resulted in similar levels of repression in the presence of the wild-type target (SNAI2) and modified targets (SNAI2-swap and SNAI2-ran) (Supplementary Fig. 5b) . These results along with the bioinformatics data suggest that this type of miRNA-mediated gene silencing might be applicable to a substantial number of endogenous miRNAs.
DISCUSSION
We show that a miRNA precursor can physically and functionally block the binding of its mature counterpart to a bona fide target contained within an mRNA (model in Fig. 6d) . In our study, we provide two examples: E2f6, a transcriptional repressor with recognized tissue-specific expression regulated by pre-miR-151, and SNAI2, a known oncogenic factor with expression regulated by pre-miR-124. Our data also suggest that these miRNA precursors may include both pri-and pre-miRNAs because they share the same sequence required for target-gene regulation. In addition to the two examples studied in detail, we developed a bioinformatics pipeline to include about 1,600 targets common to both humans and mice that are predicted to be regulated by over 100 miRNA loci.
The miR-151 precursor RNA is derived from the intron of the focal adhesion kinase gene (PTK2) that encodes a protein tyrosine kinase implicated in cell migration, invasion, adhesion 41 and various types of cancer 42 . Our studies suggest that the PTK2 transcription unit may serve as a complex proto-oncogene, and both the protein-encoding protein tyrosine kinase and miR-151 transcripts will need to be studied in more detail to establish their individual and combined roles in the oncogenic process.
Highly repetitive elements in mammalian genomes can incorporate into noncoding regions of a protein-coding gene (for example, introns and UTRs) in a relatively robust manner and provide a rapid process to fine-tune gene expression profiles that are necessary during speciation. The repeat-encoded miR-151 can target other single integrants, yet in situations in which two copies have integrated, the precursor has the potential to also bind to this region. We found a large number of potential genes targeted by other repeat-encoded miRNAs (for example, miR-28 and miR-340) that could be involved in this type of regulatory process ( Supplementary Table 3 ). However, because many miRNAs result in only small levels of individual miRNAmediated repression (rather than the Ago2-mediated cleavage of E2f6 by miR-151), it will be more difficult to prove functionality for all cases with the methods used here. Additionally, it is possible that some of these targets are in evolutionary limbo or indeterminate state, showing signs of either positive or negative selection.
The expression of several miRNAs is lost in cancer and other pathological conditions. Impairment of miRNA biogenesis promotes oncogenic transformation and tumorigenesis through downregulation of tumor-suppressor miRNAs and subsequent upregulation of target oncogenes 43 . Many of the miRNAs lost in tumors and cancer are the result of reduced processing of the transcribed precursor 11 . According to our model, the accelerated tumorigenic phenotype may result from a reduction in expression of the mature tumor-suppressor miRNAs as In situations in which the steady-state levels of the same pri-or pre-miRNAs remain high, the pri-or pre-miRNAs can regulate the repression of other target genes by mature miRNAs if the pre-miRNAs and their mature counterparts have overlapping and favorable binding sites on target genes.
npg well as a reduction in the activity of the remaining mature miRNAs because of competition with their respective precursors. Altogether, it is likely that precursor miRNAs competing with mature miRNAs and affecting their activity constitute a common regulatory event that could more precisely define important regulatory roles in development and cancer. Although our work has uncovered a new mechanism of regulating miRNA activity and gene expression, further studies are required to underscore the physiological relevance of this model. This model offers additional layers of control over existing mechanisms such as miRNA sponges or modifications in miRNA seed regions because the effect of miRNA precursors in gene regulation is target specific. Moreover, because the mature forms are generated from the intermediate precursors, this mechanism can be tightly regulated and can couple or decouple expression from activity of the miRNA to result in differential regulation of mRNAs containing the same MRE target. When taken together, these types of scenarios may further explain why miRNA levels and target-gene repression are not always correlated, and they suggest that more attention to the primary or precursor miRNAs will be required to better understand pathogenic processes in disease states. Our results challenge the dogma in which miRNA precursors are considered to be mere nonfunctional intermediates in the miRNA biogenesis pathway.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Cell culture and plasmid constructs. MEF cells and Ago2 −/− MEF cells were grown in Dulbecco's modified Eagle's medium (DMEM; Life Technologies) supplemented with 10% heat-inactivated FBS (FBS), 1% l-glutamine, 1% nonessential amino acids, 1% sodium pyruvate, and 1% pen-strep (Life Technologies). HEK293, A549 and Huh7 cells were grown in DMEM with 10% FBS and 1% l-glutamine. C2C12 mouse skeletal myoblasts were grown and maintained at subconfluent density in DMEM with 20% FBS (GM). To differentiate C2C12 myoblasts into myotubes, GM was replaced with DM (DMEM with 2% heatinactivated horse serum).
For cloning of the E2f6 reporter construct, the 3′ UTR of E2f6 was PCR amplified (primers in Supplementary Table 4 ) from mouse genomic DNA and cloned downstream of the Renilla luciferase gene in psiCHECK-2 vector (Promega). This reporter vector contained nucleotides 240 to 1141 (after the stop codon) of the mouse 3′-UTR sequence of E2f6 (NM_033270). Similarly, ARHGDIA was PCR amplified from human genomic DNA and cloned in the psiCHECK-2 vector containing a region of the 3′ UTR as previously described 35 . For cloning of the psiCHECK-2 constructs containing the 3′ UTR of SNAI2 and its derivatives (ran and swap), oligos ( Supplementary Table 5 ) purchased from IDT were chemically synthesized, and both strands were annealed and inserted downstream of the Renilla luciferase gene.
To generate the shRNA constructs for robust expression of mature miRNAs, oligos ( Supplementary Table 5 ) were chemically synthesized (IDT), and both strands were annealed and inserted between BglII and KpnI sites downstream of the U6 Pol III promoter. Pol II promoter (CMV)-based constructs (pEZX-MR04) overexpressing precursor miR-151 and miR-124-3 were obtained from GeneCopoeia.
Plasmids expressing Flag-tagged human Argonautes (Ago2 and Ago1) and YFP were obtained from Addgene (plasmids 10822, 10820 and 10825). The entire length of the E2f6 coding-sequence region along with its 3′ UTR was cloned in the Argonaute vector backbone between the NotI and EcoRI sites by the In-fusion system (Clontech) (primers in Supplementary Table 4) .
Site-directed mutagenesis was performed with the QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene) to create point substitutions, deletions or inversions at the putative miR-151-5p-or miR-151-3p-binding regions in the cloned E2f6 3′-UTR or ARHGDIA 3′-UTR regions of the psiCHECK-E2f6 or construct (primers in Supplementary Table 4 ).
RNA extraction and small-RNA northern blots. Total RNA was isolated from MEF or HEK293 cells with TRIzol (Life Technologies) 48 h after transfection. For C2C12 cells, RNA was TRIzol extracted after each day of differentiation for 5 d. Expression of miR-133a, a marker of muscle differentiation 44 , was monitored to validate the differentiation to myotubes.
For small-RNA northern blots, 10 µg of total RNA was electrophoresed on 15% (w/v) acrylamide, 7 M urea gel and transferred onto a Genescreen Plus (Perkin Elmer) membrane. Hybridization was done overnight in PerfectHyb Plus (Sigma) buffer at 65 °C with LNA probes for miR-151-5p and miR-124 (Exiqon) or at 35 °C with an oligonucleotide probe (IDT).
Quantitative PCR. Two micrograms of total RNA was reverse transcribed with the superscript II RT kit (Life Technologies) and subjected to gene expression analyses with gene-specific TaqMan probes (Mm01270320_m1 for E2f6 and Mm03306373_pri for pri-miR-151). For qPCR analysis of miR-151-5p, 100 ng of TRIzol-extracted RNA was reverse transcribed with the miRNA Reverse Transcription kit (Life Technologies). This was followed by qPCR with miRNA TaqMan probes (002642 from Life Technologies). To look for the endogenous E2f6 levels on overexpression of miR-151-5p by qPCR, MEF cells were cotransfected with GFP and sh-151-5p and were subsequently FACS sorted for GFP. For the ChIRP experiment, the pulled-down RNAs were reverse transcribed with Thermoscript (Life Technologies) and subjected to SYBR Green-based gene expression analyses (Qiagen) with primers specific for pre-miR-151, pre-miR-124 and U6 (sequences in Supplementary Table 4) as described previously 45 . qRT-PCR was performed on a CFX384 Real-Time system (Bio-Rad). Fold change was detected with ∆∆Ct calculations and normalized to mouse β-actin and U6 in gene expression and miRNA expression analyses respectively. Total RNA from lungs of 8-week-old female C57BL/6 mice or from MEF cells cotransfected with sh-scr, sh-151-5p or sh-151-3p and E2f6 overexpression construct was extracted and subjected to modified 5′ RACE with the FirstChoice RLM-RACE kit (Life Technologies). Briefly, RNA (2 µg) was ligated to a synthetic RNA (5′ adaptor) and reverse transcribed with random primers. Next, the cDNA was PCR amplified with a 5′ adaptor-specific forward primer and a gene-specific primer for E2f6 or ARHGDIA, and this was followed by a nested PCR with internal primers (sequences in Supplementary Table 4) . PCR DNA was gel purified, cloned in TOPO vector (Life Technologies) and sequenced.
Reporter assays. Dual-luciferase assays (Promega) were performed 24 h after transfection according to the manufacturer's protocol, and signals were detected by a Modulas Microplate Luminometer (Turner Biosystems). For transfection in a 24-well plate, 250 ng of psiCHECK reporter plasmids were cotransfected with 250 ng of miRNA-overexpression plasmids (sh constructs or pEZX constructs) in E 10.5 MEF cells with TransIT-LT1 (Mirus Bio) or in HEK293 and Huh7 cells with Lipofectamine 2000 (Life Technologies). Cell seeding was performed at a concentration of 2.5 × 10 4 cells for MEFs, 1.25 × 10 4 cells for Ago2 −/− and 5 × 10 4 cells for HEK293, A549, Dicer-knockout cells and Huh7 per well in a 24-well plate. For reporter assay in Dicer-knockout cells, the cells were cotransfected with Lipofectamine 3000 (Life Technologies) with an E2f6 3′-UTR reporter construct (100 ng), 20 nM duplex synthetic miR-151-5p and increasing amounts of pEZX-DM starting from 50 ng. For the miR-151-5p inhibitor study in A549 cells, a miRVANA miRNA inhibitor against miR-151-5p was used (MH11537 from Life Technologies).
A fully phosphorothiolated 18-bp LNA-DNA mixmer (Exiqon) (sequence in Supplementary Table 5 ) containing seven LNA bases predicted to block the binding of miR-151-3p to the target E2f6 3′-UTR site without inducing RNase H cleavage 46 was cotransfected in MEF cells at 50 nM with TransIT-TKO (Mirus Bio).
Western blotting. 48 h after transfection, HEK293 cells were lysed with M-PER mammalian protein-extraction reagent (Pierce) in the presence of cOmplete Ultra protease inhibitors (Roche), and samples were run on a NuPAGE Novex 4-12% Bis-Tris polyacrylamide gel (Life Technologies). Western blotting was performed with PVDF membranes, and E2f6 was detected with a rabbit polyclonal antibody (ab53061 from Abcam; validation is provided on the manufacturer's website) titered at a 1:500 dilution. As a loading control, the blot was rehybridized with an antibody against mouse β-actin (A5316 from Sigma, at a 1:10,000 dilution; validation is provided on the manufacturer's website).
In vitro RNA binding assays. A 171-bp region of the E2f6 3′ UTR containing the pre-miR-151-binding site was PCR amplified (primers containing T7 promoter sequence in Supplementary Table 4 ) and was in vitro transcribed with the in vitro transcription kit (Life Technologies) to generate the target RNA. Other modifications in the E2f6 3′-UTR target (3p-5p swap or 3p deletion) were obtained by PCR amplification of the corresponding mutated psiCHECK-E2f6 constructs and subsequent in vitro transcription (primers in Supplementary Table 4 ). The ligands (precursor miR-151(I), precursor miR-122 and miR-151-5p) containing a 5′-phosphate group were chemically synthesized (Dharmacon). RNA-RNA interactions were analyzed by electrophoretic mobility shift assays. The synthetic RNA oligos were labeled at the 3′ ends by PCP end-labeling. Binding reactions between the in vitro-transcribed RNA targets and radiolabeled synthetic RNA ligands (0.1 nM) were carried out in buffer containing 5 mM HEPES, pH 7.5, 100 mM KCl, 5 mM MgCl 2 , 0.1 µg/µl tRNA, and 3.8% glycerol at 85 °C for 5 min. This was followed by slow cooling and loading on a 5% native polyacrylamide gel. For the competition assay, the binding between the in vitro-transcribed E2f6 3′ UTR and the synthetic miR-151-5p was competed with increasing molar concentration of 1, 10 and 100 nM of a cold synthetic pre-miR-151.
Biotin pulldown assay. A synthetic pre-miR-151 RNA oligo modified at the 5′ end with a phosphate moiety and biotinylated at the 3′ end was obtained from Dharmacon. An internal U (at position 42) was substituted with a photoreactive 4-thiouridine (4-tU) to confer site-specific pre-miRNA-to-mRNA cross-linking upon long-wave UV irradiation. Pulldown was performed in HEK293 cells cotransfected with the synthetic RNA oligo and an E2f6 plasmid essentially as described earlier 47 . GAPDH expression was used as a control for enrichment in npg
